Podcasts about Clinical research

Join Elevated GP: www.theelevatedgp.com Net32.com  Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram    Peter Milgrom, DDS is Emeritus Professor of Oral Health Sciences at the University of Washington. He has been recognized throughout the world as a clinical scholar and innovator in a career spanning nearly 50 years. Among numerous awards, he received the degree of Doctor Honoris Causa from the University of Bergen, Norway, the Norton Ross Award for Excellence in Clinical Research by the American Dental Association, the Distinguished Dental Behavioral Scientist and Irwin M. Mandel Distinguished Mentor Awards of the International Association for Dental Research, the Public Service Award from the American Association of Public Health Dentistry, and the Innovator Award from the University of California, San Francisco. Professor Milgrom is best known today for having created the Access to Baby and Child Dentistry (ABCD) program in Washington State and introducing fluoride varnish and silver diamine fluoride in the United States. He is best known clinically for having co-created the Dental Fears Research Clinic at UW. Having published more than 325 research papers and books,. Dr. Milgrom has consulted with government, non-profits, and industry throughout his career.

Join medical students Binal Patel and Aashka Sheth as they discuss adolescent gynecology with pediatrician Dr. Shreeti Kapoor.  Specifically, they will discuss: What exactly is adolescent gynecology. The proper approach to taking a comprehensive history for a pediatric patient with a gynecologic chief complaint. The various causes of dysmenorrhea in the early menarche period and its presentation. The diagnostic approach to dysmenorrhea in adolescents. The approach to treatment of dysmenorrhea in a pediatric population. And how to approach addressing safe sex practices and sexually transmitted infections with adolescents. References: 21 reasons to see a gynecologist before you turn 21. ACOG. (n.d.). https://www.acog.org/womens-health/infographics/21-reasons-to-see-a-gynecologist-before-you-turn-21   Adams Hillard P. J. (2008). Menstruation in adolescents: what's normal?. Medscape journal of medicine, 10(12), 295.  Breehl L, Caban O. Physiology, Puberty. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534827/  Centers for Disease Control and Prevention. (n.d.). About heavy menstrual bleeding. Centers for Disease Control and Prevention. https://www.cdc.gov/female-blood-disorders/about/heavy-menstrual-bleeding.html  Primary dysmenorrhea in adolescents. UpToDate. (n.d.). https://www.uptodate.com/contents/primary-dysmenorrhea-in-adolescents?search=Primary+Dysmenorrhea+&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2  professional, C. C. medical. (2024, September 20). Pediatric gynecology. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/24574-pediatric-gynecology  professional, C. C. medical. (2025, February 18). Puberty. Cleveland Clinic. https://my.clevelandclinic.org/health/body/puberty   Sachedin, A., & Todd, N. (2020). Dysmenorrhea, endometriosis and chronic pelvic pain in adolescents. Journal of Clinical Research in Pediatric Endocrinology, 12(1), 7–17. https://doi.org/10.4274/jcrpe.galenos.2019.2019.s0217   Sexuality, Sexual Health, and Sexually Transmitted Infections in Adolescents and Young Adults. (2020). Topics in Antiviral Medicine, 28(2). https://pmc.ncbi.nlm.nih.gov/articles/PMC7482983/pdf/tam-28-459.pdf   UpToDate. (n.d.). Abnormal uterine bleeding in adolescents. https://www.uptodate.com/contents/abnormal-uterine-bleeding-in-adolescents-evaluation-and-approach-to-diagnosis?search=heavy%2Bbleeding&usage_type=default&source=search_result&selectedTitle=3~150&display_rank=3  

Guest: Abiodun Ologunowa Pediatric sickle cell disease treatment, particularly the use of hydroxyurea, NSAIDs, and opioids, has evolved in response to clinical guidelines and regulatory shifts, but gaps still remain in how children receive essential medications. Joining Dr. Charles Turck to discuss these national prescribing trends, disparities in care, and the implications of evolving treatment guidelines for this population is Dr. Abiodun Ologunowa. Dr. Ologunowa is a doctoral candidate and research assistant in the Department of Pharmacy Practice and Clinical Research at the University of Rhode Island College of Pharmacy.

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Sara Shanti welcomes Bill Kish and Dr. Brad Pruitt of Kenosha AI to explore how artificial intelligence can enhance efficiency and compliance in healthcare research. What is Kenosha AI, and what is its potential role in transforming healthcare and research operations? Who are the end users of Kenosha AI's products, and how are these products positioned to deliver immediate, tangible impacts for their missions? Looking ahead, how might this momentum build, and what direction could clinical research take with the advancements enabled by AI? What are the risks and concerns associated with hallucinations, synthetic data, and the trustworthiness of AI deliverables? Where can healthcare stakeholders feel comfortable jumping in on AI, and where does it make sense to wait for further development? What tasks should clinicians and researchers prioritize when exploring the potential applications of AI?   About Bill Kish Bill Kish is the CEO and Co-Founder of Kenosha AI, bringing over 30 years of dynamic experience as a technologist, entrepreneur, and leader across five successful startups. His expertise has led burgeoning companies to flourish into multi-billion-dollar enterprises, solidifying his position as an industry innovator. A graduate with honors in Computer Engineering from Carnegie Mellon University, Bill's career has been defined by groundbreaking advancements in AI and machine learning applications. He co-founded Ruckus Wireless, serving as CTO and Board Director, where his contributions shaped the company into a $400M/year business and a leader in the wireless technology industry, culminating in a $1.5 billion acquisition by Brocade. At Cogniac Corporation, Bill enabled industries to leverage AI-powered visual inspection, serving as the CEO and CTO to drive operational innovation. He also founded Jiggy AI, a boutique AI consulting firm specializing in large language model applications. Additionally, as the organizer of the Silicon Valley Machine Learning Meetup, Bill has fostered a thriving global community of over 10,000 members passionate about machine learning. About Dr. Brad Pruitt Dr. Brad Pruitt is the President and Co-Founder of Kenosha AI. With over 25 years of experience in clinical research and healthcare, including 13 years in the Contract Research Organization (CRO) industry, he specializes in revolutionizing clinical trials through advanced AI-powered tools like copilots and GPTs.  Dr. Pruitt is a seasoned executive and entrepreneur with a proven track record of leading ventures to success. He has held executive roles at top-tier CROs, served as the Founding CEO of an acquired startup, and contributed to three successful acquisitions in the past eight years. His prior leadership roles include Chief Medical Officer at Alethium Health Systems, where he developed go-to-market strategies for clinical trial innovation, and Senior Vice President of Medical Affairs at Safe Health, where he drove business expansion into connected diagnostics.  In addition to his role with Kenosha AI, Dr. Pruitt is a Principal at Prucor and serves as a mentor and advisor for healthcare and clinical trial technology companies participating in the EvoNexus incubator program. Dr. Pruitt earned his MD from Michigan State University College of Human Medicine and his MBA from UC San Diego's Rady School of Management. His academic foundation, combined with his professional achievements, positions him as a visionary leader at the intersection of technology, healthcare, and clinical research. About Sara Shanti A partner in the Corporate Practice Group in Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.   Contact Information Bill Kish Dr. Brad Pruitt Sara Shanti   Additional Resources Kenosha AI - Kenosha AI is currently offering a free trial of its RegChatTM, which is an AI-powered Clinical Regulatory Guidance Assistant that provides a simple chat interface for answering questions about global regulatory guidance using AI and official regulatory guidance documents with referenced summarizations and multi-agency comparisons. Find it at RegChat.com.  Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Tune in as Dr Daejin Adiboye, Vice President, Therapeutic Area Head, Solid Tumor Oncology, AbbVie, explores both the evolution of cancer care and his leadership style over the last two decades. Together, Daejin and Jade discuss the lessons from his time in the clinic that shaped who he is today, the move to precision medicine in oncology, his work with the Cancer Support Community in San Francisco and much more. A little more on EMJ GOLD's guest… Dr Daejin Abidoye serves as Vice President, Therapeutic Area Head for Solid Tumor Oncology at AbbVie. In this role, he is responsible for the clinical development of all assets in late oncology clinical development.  His career includes over 20 years of experience in oncology, cancer research and drug development. Prior to joining AbbVie, Daejin was the Therapeutic Area Lead for Oncology Development and Clinical Research at Gilead Sciences. He has also held various roles at Seattle Genetics and Roche-Genentech. Dr. Abidoye is a board-certified oncologist with a career in clinical practice at Scripps Health in Southern California. 

This week on Green Street, Patti and Doug talk about how rising temperatures around the world are impacting our health, and how the Trump administration is terminating the research on PFAS in bio-solid fertilizer used in agriculture. Then Denise Snyder, Associate Dean for Clinical Research at Duke School of Medicine, talks about grilling food and how cooking meat on an open flame can be hazardous to your health.

See omnystudio.com/listener for privacy information.

Jenn's LinkedIn: https://www.linkedin.com/in/jennpages/Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

The Trump administration's widespread cuts to federal funding for scientific and clinical research has adversely impacted hundreds of universities across the country.In the absence of reliable support from the federal government, where can clinical research teams look?Could the answer be private equity?Professor Gökhan S Hotamisligil, the James Stevens Simmons Professor of Genetics and Metabolism at Harvard T.H. Chan School, speaks with managing editor Jack O'Brien about the unique collaboration between Harvard and İş Private Equity, a Turkish financial organization which has pledged $39 million to fund the work of the professor and his clinical research team for a decade.As he notes, this doesn't make up for the lack of federal funding – nothing quite can – but it offers a much-needed lifeline during a turbulent time.For our Trends segment, we're previewing the Q2 earnings season for pharma companies – including what trends may impact their financial releases in the coming weeks. Music: “Deep Reflection” by DP and Triple Scoop Music. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

As an attending physician, principal investigator and academic publisher, Dr. Ashita Batavia has a deep appreciation for the importance of data in clinical development. In her role as Head of Hematology and Oncology Data Sciences, R&D, at Johnson & Johnson, she's helping shape the future of clinical trials.In this podcast episode, Dr. Batavia shares her ideas for improving clinical trials and delivering better therapies to patients. She is particularly interested in pragmatic trial designs where data and AI help reduce the burden of trial participation for patients and providers without compromising the collection of safety and efficacy data.Dr. Batavia leaves us with her belief that bringing together multimodal health data is key to fully unlocking advanced analytics capabilities in clinical research and explains why achieving a first win is the springboard to building a culture of data-driven innovation.

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In this episode, Nurse Doza explores The Master Antioxidant: 5 Ways Glutathione Supports Your Health. Learn how glutathione impacts liver detoxification, brain health, inflammation reduction, hormone balance, and chronic disease prevention. Discover practical ways to boost glutathione naturally and why it's essential for optimal energy, longevity, and overall wellness. 5 KEY TAKEAWAYS Liver Health Support: Glutathione is critical for liver detoxification and reversing fatty liver disease. Brain Function Boost: Low glutathione levels are linked to cognitive decline, Alzheimer's, and Parkinson's. Inflammation Reduction: Glutathione neutralizes oxidative stress, reducing chronic inflammation throughout the body. Hormone Balance: Proper glutathione levels help regulate estrogen metabolism and reduce breast cancer risk. Disease Prevention: Every chronic disease is linked to glutathione deficiency—raising levels improves resilience and recovery. FEATURED PRODUCT Boost by MSW Nutrition features glutathione alongside a powerful multivitamin blend, helping your body detoxify, fight inflammation, and improve energy naturally. Whether you're focused on reversing fatty liver, supporting brain health, or reducing inflammation, Boost delivers the master antioxidant directly to your system—keeping you energized and protected every day.

In today's episode, supported by Thermo Fisher Scientific, we had the pleasure of speaking with Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP, about the FDA approval of the Oncomine DX Express Test for use as a companion diagnostic for sunvozertinib (Zegfrovy) in EGFR exon 20 insertion mutation–positive non–small cell lung cancer and for use in tumor profiling. Dr Ganti is a professor in the University of Nebraska Medical Center (UNMC) Division of Oncology & Hematology, the Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, and the associate director for Clinical Research at the Fred & Pamela Buffett Cancer Center in Omaha. Dr Cushman is the Henry F. Krous Professor of Pathology, a professor in the UNMC Department of Pathology, Microbiology and Immunology, director of the Division of Diagnostic Molecular Pathology and Human Genetics, medical director of the Molecular Diagnostics and Personalized Medicine Laboratory at Nebraska Medicine, director of the Molecular Genetic Pathology Fellowship Program, and associate director of the UMNC MD-PhD Scholars Program.  In our exclusive interview, Drs Ganti and Cushman discussed the significance of the launch of the Oncomine DX Express Test, the benefits and limitations of rapid next-generation sequencing, and features that set Oncomine DX apart from other available tests. 

Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials.Topics Covered:CTI's history and expansion in the Middle East & AfricaLocal expertise and regulatory evolutionVaccine research and biotech investmentGene therapy, AI, and the future of clinical trialsClick Here for more Info about CTI in the MEA RegionTimestamps:00:00 – Meet Alaa and his background00:56 – CTI's regional roots and growth02:19 – Why local presence matters03:20 – Clinical research evolution in the region05:02 – COVID-19's transformative impact06:44 – Vaccine research and biotech hubs08:33 – Advice for sponsors entering the region10:33 – Changing perceptions and realities12:52 – CTI's readiness and expansion strategy14:06 – Future growth and innovation15:42 – Alaa's excitement for the future of research

In this episode, recorded live at the 51st Academy Annual Meeting and Scientific Symposium in Atlanta, host Seth O'Brien, CP, FAAOP(D), welcomes Russ Lundstrom, Director of Clinical Research and Services at Ottobock and recipient of the Thranhardt Lecture Series Award. Lundstrom shares insights from his research on goal attainment and reduced reliance on walking aids, focusing on the use of real-world evidence alongside randomized controlled trials. The conversation explores the clinical impact of the C-Brace, including its influence on walking speed, fall reduction, and patient quality of life. Additional topics include goal setting, the value of individualized care, the role of physical therapy, and the importance of clinical judgment when introducing new technologies.   O&P Clinical Care Insiders is produced by Association Briefings. 

In this episode of Style DNA I recorded a special bonus episode with Ro Huntriss, Chief Nutrition Officer (I love this title) of this Season's sponsor, The Simple Life App. Health and Wellbeing have always fascinated me and so I was not only curious to interview Ro on the benefits of Intermittent Fasting but I wanted to discuss how the way we live, and eat, can influence the way we dress.   Just to give you a little background, Ro Huntriss is an award-winning, London-based Registered Dietitian with 14 years of experience working across the NHS, private practice and commercial business. Ro has specialist clinical experience in a number of areas including weight management, metabolic health, gastroenterology and women's health and seven years of experience working within international health tech. She has two Master's degrees, the first in Advanced Nutrition and the second in Clinical Research and is the Chief Nutrition Officer at Simple App, an AI weight loss coach with 17M downloads globally, recently crowned Best Virtual Health Coach in the 2025 Med Tech Breakthrough awards.   Ro's is a passionate advocate for how digital tools can empower healthier habits and drive measurable outcomes across populations and one of her key missions is to make credible, personalised nutrition support accessible at scale...yes!   We discussed our personal Intermittent Fasting journeys...I am a genuine advocate of IF and have been for many     years ... I find that it keeps me focused and has helped hugely with balancing my blood sugar levels.     Of course we discuss Style and body confidence, when we are feeling good in our bodies we tend to have more enjoyment in our clothes... I've always believed that personal style starts from within.   But Ro isn't all about strict rules...she is an advocate of "80/20" (me too)...whereby 80% of the time you are consistent in your habits and nutrition and 20% of the time less so... ultimately it is about finding what works best for you personally.   Thank you Ro for being such a great guest xx --- A message from our season sponsor: Join the millions of people hitting their weight loss goals with Simple. To start your personalized plan complete the quiz at simple.life/amanda and use code AMANDA for 70% off. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In episode #382 of The Hormone Puzzle Podcast, our guest Ro Huntriss, talks about Food for Fertility. More about Ro: With 14 years of experience working as a Registered Dietitian across the NHS, private practice and commercial business, Ro is the founder of Fertility Dietitian UK. She has two Master's degrees in Advanced Nutrition, and Clinical Research, is a published academic author, and the author of Deliciously Healthy Fertility. Ro acts as the Chair of the Women's Health and Fertility Specialist Group of the British Dietetic Association, is the nutrition representative for the European Fertility Society committee and is a member of the Parliamentary and Scientific Committee APPG. Thank you for listening! This episode is made possible by Puzzle Brew's Fertility Tea: https://hormonepuzzlesociety.com/fertility-tea Follow Ro on Instagram: @‌fertility.dietitian.uk Follow Dr. Kela on Instagram: @‌kela_healthcoach Get your FREE Fertility Meal Plan: https://hormonepuzzlesociety.com/ FTC Affiliate Disclaimer: The disclosure that follows is intended to fully comply with the Federal Trade Commission's policy of the United States that requires to be transparent about any and all affiliate relations the Company may have on this show. You should assume that some of the product mentions and discount codes given are "affiliate links", a link with a special tracking code This means that if you use one of these codes and purchase the item, the Company may receive an affiliate commission. This is a legitimate way to monetize and pay for the operation of the Website, podcast, and operations and the Company gladly reveals its affiliate relationships to you. The price of the item is the same whether it is an affiliate link or not. Regardless, the Company only recommends products or services the Company believes will add value to its users. The Hormone Puzzle Society and Dr. Kela will receive up to 30% affiliate commission depending on the product that is sponsored on the show. For sponsorship opportunities, email HPS Media at media@hormonepuzzlesociety.com

As global clinical trials become more competitive and data-driven, Latin America is stepping up with a new global standard in clinical trial quality. In this episode, Etienne Nichols speaks with Julio Martinez-Clark, CEO of BioAccess and a key advocate for clinical site certification in Latin America. They discuss the launch of the GCSA certification and IAOCR accreditation now available in the Americas, exploring how these standards improve site credibility, de-risk clinical trials, and offer faster pathways for medtech market access. From regulatory advantages to site selection strategies, this episode is essential listening for sponsors, CROs, and MedTech leaders navigating global trials.Key Timestamps00:02 – Introduction to Julio Martinez-Clark and episode overview02:10 – What is GCSA and IAOCR certification?06:00 – Why certification is emerging now: volume, complexity, and patient safety09:42 – Certification structure: site vs. individual requirements13:45 – The Colombian model: First mover in Latin America17:55 – Global harmonization vs. local certification pitfalls21:30 – Measuring ROI of certified vs. non-certified sites26:15 – Future of global site certification and Latin America's role30:00 – Regional differences: speed vs. patient pool in trial site selection36:15 – Final thoughts on FDA trends and LATAM's emerging positionQuotes“It's appalling that in an industry that deals with lives, there was no global standard to certify site or individual competency—until now.”– Julio Martinez-ClarkWhy it matters: This underscores the critical gap in clinical research infrastructure and the urgent need for standards like GCSA.“You can't measure quality without a shared framework. Certification levels the playing field globally.”– Julio Martinez-ClarkWhy it matters: This highlights how global certification allows consistent benchmarking across clinical sites, benefitting sponsors and patients alike.Key TakeawaysGCSA Certification Elevates Site Credibility: Clinical sites with GCSA certification are fast-tracked for sponsor consideration, leading to better trial access and more robust patient recruitment.IAOCR Accreditation Validates Individual Competency: For investigators, coordinators, and site managers, individual accreditation under the UNESCO-backed IAOCR framework offers a portable, verifiable skillset.Latin America Offers Dual Advantages: With rapid recruitment and cost-effective data generation, LATAM is uniquely positioned to lead in globally certified trials—especially Colombia, which already mandates certification.Global Harmonization is Critical: Fragmented local certifications can deter sponsors. A unified global framework like GCSA simplifies compliance, increases efficiency, and builds trust.The FDA Bottleneck May Shift Market Entry: With regulatory delays in the U.S., more medtech firms may turn to Latin America for first-in-human trials and initial commercialization.ReferencesJulio Martinez-Clark on LinkedInBioaccess LATAMIAOCR – International Accreditation Organization for Clinical ResearchEtienne Nichols on LinkedInMedTech 101: What

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Episode 305 hosts Dr Lisa Dinley (Dental Surgeon from Nottingham, UK) In our 'Masterclass Series' we host global experts to teach us about fillers, bio-stimulators, bio-remodellers, polynucleotides, exosomes and other products. (For toxin insights, check out our other mini-series, 'The Tox Talks') In Chapter 6 we explore the new PDLLA-based biostimulators called Juvelook and Lenisna. These are made by Vaim based in South Korea and are soon to be distributed globally by Fillmed.  We cover the products applications, safety profiles and perceived benefits when compared to other well known biostimulators. Lisa shares her treatment protocols, early insights and research using the products in combination.  00:00 Introduction to Inside Aesthetics 03:02 Special Guest: Dr. Lisa Dinley 03:20 Dr. Lisa's Background in Aesthetics 04:26 The Dentist-Doctor Debate in Aesthetics 06:20 Introducing Juvelook and Lenisna 12:46 Understanding Collagen and Elastin 18:13 Practical Applications and Patient Considerations 25:07 Reconstitution and Injection Techniques 29:41 Understanding Glass Transition Temperature in Biostimulators 30:22 Addressing Complications and Risks 32:18 Treatment Recommendations and Techniques 33:54 Patient Results and Expectations 35:43 Comparing Biostimulators in the Market 37:42 Exploring Treatment Areas Beyond the Face 44:35 Safety Data and Clinical Research 50:23 Introducing New Products in Clinical Practice 54:50 The Future of Regenerative Aesthetics 01:00:14 Conclusion and Final Thoughts   CLICK HERE TO JOIN OUR PATREON FOR ON DEMAND EDUCATION & SUPPORT CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST JOIN OUR LISTENER WHATSAPP GROUP & SEND US YOUR COMMENTS, SUGGESTIONS OR JUST SAY HI! CONTACT US

Send us a textDr. Michael Koren hosts Brian Achille, the Chief Operating Officer of the Certified Clinical Research Professionals Society (CCRPS). Brian draws a distinction between doing clinical research casually and doing it professionally. The distinction highlights how professional training and attitudes prove to be a benefit to research and the community at large. The duo discuss how CCRPS offers training for many different clinical research roles, from "entry level" to physicians.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Joan Guzmán-Bofarull, and senior author, Marta Farrero, both of the Hospital Clinic de Barcelona in Spain. They join to discuss their paper, “Regional differences in primary graft dysfunction: A report from the international consortium on PGD.” The discussion explores: The international consortium on PGD, the composition of the study, and the practices of the included countries in the United States, Canada, and Europe Hypotheses on why the study shows better 30-day and 1-year outcomes in the United States Considerations transplant centers can take regarding recipient management and donor heart selection For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Effects of Combining Coronary Calcium Score With Treatment on PlaqueProgression in Familial Coronary Artery Disease A Randomized Clinical Trial JAMA 2025. Discussion by:Guest: Michael J. Blaha, MD, MPHProfessor of Cardiology and Epidemiology and presently serves as theDirector of Clinical Research for the Johns Hopkins Ciccarone Center for thePrevention of Cardiovascular DiseaseDirector of the Cardiometabolic ClinicProgram Director for the Preventive Cardiology Fellowship.2. Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition. Alzheimer's Dement. 2025. Discussion by:Guest:Michael Devano, DO Attending Family Physician Christiana Care Health System3. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. The New England Journal of Medicine. Discussion by:Guest:Joseph Gonnella, MD Resident– Family MedicineResidency Program, Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Learn how flexibility, real-time control, and localized trial expertise are reshaping the future of CRO's from the man redefining it. Listen in as Ardian Latifi breaks down why Southern CDC's sponsor-first model is more than an experiment; it's the new path forward.In this episode of Spark Time!, we sit down with Dr. Ardian Latifi, founder and CEO of Southern Clinical Development Consulting (Southern CDC). Ardian shares how his frustration with big, bureaucratic CROs inspired a bold, leaner model. One built for biotech sponsors, not shareholders.Forget the one-size-fits-all, multi-billion-dollar corporate CROs. Ardian's approach puts sponsors back in the driver's seat, with modular teams, consultants limited to just 2–3 projects at a time, and radically transparent pricing and timelines. No hidden handoffs or surprise delays. Just direct access, expert-driven trials built for speed and clarity.

Send us a textSurveys show that 97-99% of participants who participate in one clinical research study would sign up for another. We wind out why in this episode, recorded in front of a live audience. Dr. Michael Koren and Nalini Jones, CCRC are joined by three clinical research patients to review the good, the bad, and the ugly in the history of clinical research. They also discuss the ins and outs of how the clinical research process works and share patient stories of their experiences as research participants. Step into a behind-the-scenes look at how we get from medical ideas to medical treatments and how the process leaves a lasting impact on patients and the legacy of knowledge.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

LINK TO ACRO'S RBQM SUMMARY REPORT: https://www.acrohealth.org/rbqm-summary-report/In this episode, ACRO RBQM Working Group members Lauren Garson (Veeva), Cris McDavid (Parexel), and Jennifer Stewart (Premier Research) joined ACRO's Good Clinical Podcast to discuss key takeaways from ACRO's annual RBM/RBQM Landscape Survey. Since 2019, ACRO's RBQM survey has dug into trial-level data on industry adoption of RBM and RBQM components. Informed by conversations with FDA, the aim of the survey is to evaluate ACRO member companies' adoption of risk-based monitoring to better understand how the larger framework of risk-based quality management (RBQM) are being adopted across the clinical trial industry.  

Lee's LinkedIn: https://www.linkedin.com/in/lee-eifler-6689401b2/David's LinkedIn: https://www.linkedin.com/in/david-lahaie-2997535/Jaime's LinkedIn: https://www.linkedin.com/in/jaime-valles-2a1728221/

Send us a textAI promises to revolutionize clinical trials and reshape regulatory oversight. But is the pharma industry ready? And can the FDA keep pace with the technology? In this episode of the HealthBiz Podcast, host David Williams is joined by Tom Doyle, Chief Technology Officer of Medidata, to discuss the promises and potential pitfalls of AI in clinical trials.

Drs. Daina Parent and Ryan Bradley take a deep dive into the microbiome and it's influence on whole body health, and cover highlights on clinical research focused on gut health. They also touch on soil health and environmental toxins and the impact on the microbiome. Dr. Ryan Bradley is a Naturopathic Physician with a Master's Degree in Public Health and Epidemiology. He is currently a professor and has completed 8 years of clinical research training. He leads research initiatives at the intersection between public health and integrative and complimentary medicine. 2:00 – Dr. Bradley's Journey towards current career and passion for research; his interest in mechanisms of natural products and clinical research; clinical practice was focused on cardiometabolic disease, Diabetes, and more 5:10 – New initiatives after closing clinical practice 5 years ago - now focuses on clinical research / clinical trials; also focuses on Mentorship through National Center for Complimentary and Integrative Health, branch of NIH for Complimentary Medicine 8:30 – Importance of research for clinicians – shifts the way practitioners practice, especially in Complimentary and Integrative Medicine which has a population of clinicians thirsty for evidence of effectiveness of Complimentary and Integrative strategies, philosophy, and frameworks/protocols 11:55 – Historical Knowledge of effectiveness of Naturopathic Medicine, “the science is finally catching up to our practices”; example – gut health, dysbiosis, leaky gut syndrome; “We finally have the scientific tools to explore these concepts in greater detail.” 13:50 – Gut Health and Naturopathic Medicine – trends and changes in gut health practice; general public is paying more attention to their gut health; rapid innovation, especially with probiotics, postbiotics, prebiotics, and fibers; does the science support large doses of probiotics?; Is the practice outpacing the evidence?; What will the future of microbiome research and awareness look like? 20:40 – Gut Health as connected to global effects throughout the whole body – hormonal health, immune health, brain health; effects of environmental factors like air and water quality influence gut health 23:55 – Current research in the gut health space and how it translates into clinical practice 34:32 – NIH Grants for mentorship, gut health, mind-body practices and effects on anxiety, and more 40:40 – Mind Body Medicine and connection to Gut Health 42:15 – Will gut health continue to be at the forefront of medicine and medical research? Personalized probiotics and AI; potential natural GLP-1 agonists; increased public awareness to demand better foods, less environmental toxins in food, water, and air 49:55 – SOIL HEALTH: The hope for the near future: increased public understanding of soil health and connection to gut health and overall well-being; gut health linked to soil health, food quality, and farming practices; everything is interconnected 53:20 – Integrative Health and it's impact on public health

Today, we cover ASCO 2025 in the genitourinary space, specifically bladder and renal cancer. Dr. Enrique Grande, a renowned oncologist and Program and Clinical Research lead of MD Anderson Cancer Centre, Madrid, joins us. This is a mega episode where we cover AMPLITUDE, JAVELIN MEDLEY, CHECKMATE 901 and NIAGARA, advancing urothelial cancer care; SEAR 02 and the CReST trial, pushing boundaries in bladder cancer; CHECKMATE 214; LITESPARK-005 and LITESPARK-004, showcasing belzutifan's promise; and KEYNOTE-564, adjuvant therapy for kidney cancer. Stay tuned for an insightful conversation on how these trials may be transforming patient outcomes!Studies discussed in the episode:CHECKMATE 901NIAGARACHECKMATE 214CREST trialSEAR 02LITESPARK 004/005AMPLITUDEJAVELIN MEDLEYFor more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr. Jockers and Dr. William Hsu dive into how nourished fasting can reduce insulin resistance, activate autophagy, and slow aging. They discuss how the fasting mimicking diet triggers cellular repair while still providing nourishment.   Learn how nutrient-sensing pathways like mTOR and IGF-1 influence metabolic health and why modern eating habits may accelerate aging. Dr. Hsu explains how short-term fasting can promote healing by tapping into the body's natural survival mechanisms.   Discover how to apply nourished fasting in your life with the ProLon protocol and why a few cycles a year can significantly improve your healthspan.   In This Episode: 00:00 Introduction to the Fast Mimicking Diet 02:49 Interview with Dr. William Hsu: Metabolic Health and Fasting 04:48 The Science Behind Fasting and Cellular Healing 06:49 The Evolutionary Perspective on Fasting 09:22 Understanding Nutrient Sensing Pathways 14:33 The Nobel Prize-Winning Research on Autophagy 17:44 The Concept of Fasting Mimicking Diet 21:25 Exploring the Benefits of Fasting Mimicking Diet 22:01 The Science Behind Fasting and Systemic Health 23:22 The Role of Lifestyle Medicine 24:16 Understanding Digestive Health and Stomach Acid 26:10 Hormetic Stress and Health Benefits 27:16 Clinical Research on Fasting Mimicking Diet 31:32 Practical Application of Fasting Mimicking Diet 32:43 Personalized Programs for Health Conditions 35:22 The Future of Lifestyle Medicine 40:54 Final Thoughts and Call to Action     Still cooking with seed oils? That could be fueling inflammation. I've switched to Paleovalley's 100% grass-fed beef tallow—it's rich in CLA, packed with flavor, and stable at high heat. It's one of the cleanest, most nutrient-dense fats you can cook with. Head to paleovalley.com/jockers and use code JOCKERS for 15% off your order. Heartburn doesn't mean you have too much stomach acid—it usually means you don't have enough. That's why I recommend Just Thrive's Digestive Bitters. They help ignite stomach acid, enzymes, and bile so you can finally break down food the way you're supposed to. Go to justthrivehealth.com and use code JOCKERS to save 20%.       "Autophagy is your body's self-cleaning cycle—and most people never turn it on." ~ Dr. Jockers     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean  TuneIn Radio     Resources: Get 15% off Paleovalley Beef Tallow: paleovalley.com/jockers – Use code JOCKERS Save 20% on Just Thrive Digestive Bitters: justthrivehealth.com – Use code JOCKERS       Connect with Dr. William Hsu:  Website: https://l-nutra.com/portfolio/william-hsu-md/ Prolon 5 Day Fasting Mimicking Diet: https://prolonlife.com/       Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/     If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/  

Dr Gorga from the Charles Woodson Fund for Clinical ResearchSee omnystudio.com/listener for privacy information.

Drs. Jeffrey Jensen and Johanna Richey welcome Dr. Najwa Javed to Dean's Chat! Dr. Javed is a board certified podiatrist and founder of E'MAR Italy. She holds a Bachelor of Science in Biochemistry and Ethno-Anthropology from the University of Oklahoma and she has a Masters of Public Health in Biostatistics and Clinical Research with honors from the University of North Texas Health Science Center. This episode is sponsored by Bako Diagnostics! Dr. Javad received her Doctorate of Podiatric Medicine from the College of Podiatric medicine with Samuel Merritt University and she completed her surgical residency training program through the VA Palo Alto conjunction with Stanford university consortium. Join us, as she discusses the inspiration from experiences with her grandmother's health they got her interested in medicine.   Dr. Javed is the managing partner and CEO of Silicon Valley Podiatry Group and she's also the founder of E'MAR Italy, a luxury footwear brand built with patent pending medical technology for the modern women. Tune in, as we discuss “all things podiatric medicine” for this special entrepreneur episode!  She is part of the Female Founder Collective, a network of businesses led by women, supporting women. Her company won FAST Company's World Changing ideas Award, the Paysafe Entreprenista Pitch Competition and has been featured in several media outlets! She was recently featured as a speaker at the Synergy OPEN Silicone Valley Forum talking about “Scaling while staying private.” She is the recipient of the Philip Gardner award for excellence in podiatric medicine and she brings unique expertise as both practicing physician as well as Silicon Valley founder, and entrepreneur.  We hope you enjoy! https://najwajaved.com/ https://shopemar.shop/ https://bmef.org/ https://www.apma.org/

June 17, 2025 ~ Charles Woodson, former Michigan Wolverine and NFL football players, joins Chris, Lloyd, and Jamie to discuss the Woodson Fund raising money for clinical research at C.S. Mott Children's Hospital. Photo: Junfu Han / USA TODAY NETWORK

In 2024, ACRO announced its D&I Site Resource Grants Program. Designed to support an innovative 12-month pilot project, the site resource grants act as a platform to incubate innovative strategies for improving representative enrollment in clinical research.  On this episode, site grantee representatives Dr. Ammara Mushtaq, MD (Brooklyn Clinical Research), Dr. Lovie Negrin, APRN (Randomize Now), and Sandra Carmona Torres, BSN (K2 Medical Research) join the podcast to discuss the lessons learned through implementing their pilot projects so far. They dive deeper into how sites can address barriers to participation, the need for consistent investment in building trust and engaging local community members, and the state of clinical research from a site perspective.

Alright so we've talked about contract research organisations and vendors and suppliers lots, but it's time to put on our legal hats and discuss contracting! Why is it needed, why is it so widespread, which kinds of things can be contracted and what does GCP have to say about it. If this is what you want to know - you're in the right place! Remember, you can get in touch with us via clinical.research.intro@gmail.com. Please feel free to send questions, comments and compliments for Elyse to read out on the pod. It's fun to make Debbie squirm! Credit to our friend Sam Winnie for their awesome and cute music. Check out their work at https://www.samwinnie.com/ References - ICH_E6(R3)_Step4_FinalGuideline_2025_0106.pdf

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Today, we are joined by the esteemed Dr. Jay Chhablani, a distinguished professor of ophthalmology and vitreoretinal surgeon at the Department of Ophthalmology, University of Pittsburgh. As the Director of Clinical Research at the UPMC Vision Institute, Dr. Chhablani stands at the forefront of cutting-edge advancements in eye care. Embark on a fascinating exploration as Dr. Chhablani, a retina specialist and surgeon, shares his wealth of knowledge on retinal diseases, ranging from bothersome floaters to age-related macular degeneration. Delve into the intricacies of ophthalmic surgeries, including the delicate art of retinal detachment repair. Press play to discover: The origins and prevention of eye floaters, along with effective treatment approaches. Conditions warranting surgical intervention for floaters. Navigating through complications associated with common ophthalmic surgeries and procedures. Distinguishing between the two primary forms of macular degeneration. The mechanics of novel drug therapies in slowing the progression of retinal diseases. Eager to learn more? Tune in and explore more at Jay Chhablani, MD | Department of Ophthalmology | University of Pittsburgh. Episode also available on Apple Podcasts: apple.co/30PvU9C

In this episode, Jonathan Norman (Director, Localisation Services, YPrime) and Laura Russell (Senior Vice President, Head of Data and AI Product Development, Advarra) join the podcast to discuss how artificial intelligence is transforming today's clinical operations. They dive deeper into how AI can be used to improve protocol design, drive efficiency in localization processes, and modernize clinical operations to expand access to trials and get treatments to patients sooner. 

Join Elevated GP: www.theelevatedgp.com Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Markus B. Blatz is Professor of Restorative Dentistry, Chairman of the Department of Preventive and Restorative Sciences and Assistant Dean for Digital Innovation and Professional Development at the University of Pennsylvania School of Dental Medicine in Philadelphia, Pennsylvania, where he also founded the Penn Dental Medicine CAD/CAM Ceramic Center, an interdisciplinary venture to study emerging technologies and new ceramic materials while providing state-of-the-art esthetic clinical care. Dr. Blatz graduated from Albert-Ludwigs University in Freiburg, Germany, and was awarded additional Doctorate Degrees, a Postgraduate Certificate in Prosthodontics, and a Professorship from the same University. Dr. Blatz is co-founder and past President of the International Academy for Adhesive Dentistry (IAAD) and a founding member of the European Academy of Digital Dentistry (EADD). He is a board-certified Diplomat in the German Society for Prosthodontics and Biomaterials (DGPro) and a member of multiple other professional organizations, including the American Academy of Esthetic Dentistry, the European Academy of Esthetic Dentistry, the International College of Prosthodontists, the American College of Prosthodontists (honorary member), Academy of Osseointegration, and O.K.U. Honor Dental Society. He is the Editor-in-Chief of Compendium of Continuing Education in Dentistry, Associate Editor of the Journal of Esthetic and Restorative Dentistry and of Quintessence International, Section Editor for the International Journal of Prosthodontics, and serves on the editorial boards of numerous other recognized scientific dental journals. He is coauthor of the international bestseller “evolution – contemporary protocols for anterior single-tooth implants”, which has been translated on over 8 languages. Prior to joining Penn Dental Medicine as Chairperson of the Department of Preventive and Restorative Sciences in September 2006, Dr. Blatz was at Louisiana State University (LSU) Health Sciences Center School of Dentistry in New Orleans, where he served as Chairman of the Department of Comprehensive Dentistry and Biomaterials and Assistant Dean for Clinical Research. During his tenure at LSU, Dr. Blatz also directed the Masters of Science in Oral Biology Program and was a senior faculty member in the Department of Prosthodontics. From 1994 to 1998 he was an Assistant Professor and from 1998 to 1999 a senior faculty member in the Department of Prosthodontics at Albert Ludwigs University Freiburg School of Dentistry in Freiburg, Germany. A widely published and internationally respected lecturer, Dr. Blatz's main focus within clinical practice and research is esthetic dentistry with an emphasis on implantology and dental materials, particularly ceramics and adhesion. Dr. Blatz is the recipient of multiple teaching and research awards and has published and lectured extensively on dental esthetics, restorative materials, and implant dentistry. He was recently named one of the “World's Top 100 Doctors in Dentistry”.

Expanding access to clinical trials in community oncology settings is essential to improving diversity, equity, and inclusion in cancer research. In this episode, CANCER BUZZ speaks with clinical research coordinator, Oluwakemi “Kemi” Oladipupo, MSHS, MPH, BSN, RN, CCRP, whose cancer center recently participated in a foundational oncology clinical trials course, developed by ACCC and the Association of Clinical Research Professionals (ACRP) to help cancer programs expand availability of trials to traditionally underserved communities. Oladipupo shares how this training prepared their center for the challenges of a growing research program, the progress they've made, and the pivotal role of clinical research coordinators in expanding research programs and improving patient access to clinical trials.   Oluwakemi “Kemi” Oladipupo, MSHS, MPH, BSN, RN, CCRP Clinical Research Coordinator Touro-Cancer Center New Orleans, LA   “We know that diversity is a big point, not only as per new FDA guidance, but [to] ensure that every participant is given an equal opportunity to hear about the study. [Our] approach is not to target a certain group of individuals. Really the approach is to target any individual that looks potentially eligible.” - Oluwakemi “Kemi” Oladipupo   Resources:  Community Oncology Can Close the Gap in Cancer Research Increasing Clinical Trial Accrual Through the Implementation of a Clinical Trials Navigator The Role of the Clinical Trials Navigator — [MINI PODCAST] EP 129 Human-Centered Design: A Possible Solution to Rural Clinical Trial Enrollment

Jaime's LinkedIn: https://www.linkedin.com/in/jaime-valles-2a1728221/Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Julio Martinez-Clark teamed up with his cardiologist brother and other doctors to help speed up the clinical trials part of the process. Julio's team at bioaccess® is moving medicine forward quicker by helping startups and researchers get the data from clinical trials in other countries. Advancements can now come to market quicker while also helping suffering people in countries that do not have the means to afford the proper medical care. This saves time, money, and people.Julio Martinez-Clark is the co-founder and CEO of bioaccess®. Julio believes Latin America is an untapped destination for Medtech clinical research. Since 2010, Julio has supported +100 Medtech in operationalizing successful clinical trials in several countries in Latin America. Julio was the chairman of the board of the Association for the Advancement of Clinical Research in Colombia (AVANZAR). Julio writes a column at Med Device Online, where his articles have been "Featured Editorials" on several occasions. Julio hosts the LATAM Medtech Leaders podcast, interviewing Medtech leaders who have succeeded in Latin America.Julio has a wealth of experience in various fields, including serving as an advisor to the CEO of Amavita Heart and Vascular Health™, the most extensive cardiovascular practice in South Florida, an advisor to government agencies in Colombia looking to position the country as a clinical trial destination, and a mentor to startups at Macondo Labs, a top incubator in Colombia.Learn more at www.bioaccessla.com and connect with Julio on Linkedin @juliomartinezclark Visit ConfidenceThroughHealth.com to find discounts to some of our favorite products.Follow me via All In Health and Wellness on Facebook or Instagram.Find my books on Amazon: No More Sugar Coating: Finding Your Happiness in a Crowded World and Confidence Through Health: Live the Healthy Lifestyle God DesignedProduction credit: Social Media Cowboys

In the latest collaboration between ACRO and TransCelerate BioPharma, Cris McDavid (Senior Director, Global Clinical Operations, Parexel) and Tashan Mistree (Senior Director, Business Operations, Office of Chief Medical Officer, GSK) join this week's episode to discuss the impact of ICH E6(R3) from their different vantage points in the clinical research industry. They dive deeper into their experiences implementing the new guidance at their respective companies, the new opportunities that R3 has created in the partnership between CROs and sponsors, and how they envision the future state of R3 once industry has fully embraced the guidance. FIND ACRO & TRANSCELERATE'S ICH E6(R3) TOOLS & RESOURCES HERE: https://www.acrohealth.org/initiatives-hub/interpreting-ich-e6r3/ 

Dive into the world of generative AI with Silvio Galea, chief data analytics officer, WCG, and Kyle Miller, lead data scientist, WCG. In this compelling episode of WCG Talks Trials, we explore how Generative AI can improve clinical research workflows from meticulous data entry to efficient data validation. Uncover the technology behind AI's ability to assist in document updates, highlight transcription biases, and digitize complex data for predictive analytics. Understand the importance of human oversight and practical applications that can optimize how clinical trials are conducted. Whether you're curious about AI's role in reading dense documents or leveraging pipelines for innovation, this episode provides the insights you need.Guests:Silvio Galea, chief data and analytics officer, WCGKyle Miller, lead data scientist, WCG

Copaiba Essential Oil has quickly become one of the most talked-about essential oils at doTERRA, and for good reason. In this episode, host Jared Auger is joined by Dr. Nicole Stevens, Vice President of Clinical Research, to explore what makes doTERRA's Copaiba Essential Oil and Softgels so unique.   From the chemistry behind the essential oil to the latest internal research, this conversation offers valuable insights into how Copaiba Essential Oil is sourced, tested, and used as part of a daily wellness routine.   In this episode, you'll learn:   What Copaiba essential oil is and how it's different from CBD How Copaiba interacts with the body's systems What makes doTERRA's sourcing and quality standards unique The research behind how Copaiba is processed and studied How Copaiba can be used in your daily routine with confidence   Whether you're curious about how Copaiba Essential Oil compares to CBD or you're looking for expert-backed insights on this oil's potential, this episode is packed with clarity and science.